Global Parkinson’s Disease Treatment Market 2017-2024
Global Parkinson’s Disease Treatment Market is expected to reach USD 6.48 Billion by 2024 from USD 4.02 Billion in 2016 at CAGR of 6.15% (Detailed analysis of the market CAGR is provided in the report).
Parkinson’s Disease are combination of progressive, degenerative neurological motor disorder, primarily affecting the dopaminergic cells of the brain. Rigidity, tremor, bradykinesia and postural instability are some of the common symptoms of Parkinson’s Disease.
Global Parkinson’s Disease Treatment Market is segmented by drug class, patient care setting, distribution channel, and geography. Drug Class segment is sub segmented as levodopa/carbidopa, dopamine receptor agonists, Mao-inhibitors and others. Distribution channel segment is classified as hospital pharmacies, retailer pharmacies and online pharmacies. Hospital pharmacies segment is expected to dominate the market during forecast period. Rising number of patient visits to the hospital due to the availability of diagnostic laboratories is expected to fuel the segment growth. Patient care setting segment is bifurcated as hospitals and clinics. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America.
Increasing prevalence and rise in incidences of Parkinson’s disease across the developed countries are trending the overall Global Parkinson’s Disease Treatment Market. However, availability of conventional treatment methods will restrain the market growth. APAC is expected to register highest growth rate in Parkinson’s Disease Treatment Market during the forecast period followed by North America and Europe. Increasing number of generic drug manufacturers and rising aging population in this region will fuel the Parkinson’s Disease Treatment Market in APAC region.
• Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Parkinson’s Disease Treatment Market analysis and comprehensive segmentation with respect to the drug class, patient care setting, distribution channel, and geography to assist in strategic business planning • Global Parkinson’s Disease Treatment Market analysis and forecast for five major geographies North America, Europe, Asia pacific, Middle East & Africa, Latin America and their key regions
Research methodology used in this report contains various secondary sources including Bloomberg, Hoovers, and Factiva. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of this market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Parkinson’s Disease Treatment Market globally.
More Information : https://www.maximizemarketresearch.com/market-report/global-parkinsons-disease-treatment-market/6655/
Some quick example text to build on the card title and make up the bulk of the card's content Some quick example text to build on the card title and make up the bulk of the card's content Some quick example text to build on the card title and make up the bulk of the card's content.